Dow Up2.00% Nasdaq Up1.66%

Eli Lilly and Company (LLY)

-NYSE
71.27 Down 0.15(0.21%) Feb 12, 4:02PM EST
|After Hours : 71.20 Down 0.07 (0.10%) Feb 12, 6:39PM EST
ProfileGet Profile for:
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285
United States - Map
Phone: 317-276-2000
Website: http://www.lilly.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:41,275

Business Summary 

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. It also provides neuroscience products for the treatment of major depressive disorders, diabetic peripheral neuropathic pain, anxiety disorders, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorders; depressive, obsessive-compulsive, bulimia nervosa, and panic disorders; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains. In addition, the company offers products for the treatment of non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products for the treatment of erectile dysfunction and benign prostatic hyperplasia, thrombotic cardiovascular events, and cardiac ischemic complications. Further, it provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine, cattle, and poultry; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry; and chewable tablets that kill fleas and prevent flea infestations, heartworm diseases, roundworm diseases, hookworm diseases, and whipworm diseases. Additionally, the company offers products to treat chronic manifestations of atopic dermatitis and congestive heart failure in dogs; chronic allergic dermatitis and kidney diseases in cats. It has collaboration agreement with ZP Opco, Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Eli Lilly and Company

Corporate Governance 
Eli Lilly and Company’s ISS Governance QuickScore as of Feb 1, 2016 is 9. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 9; Compensation: 9.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Dr. John C. Lechleiter Ph.D., 62
Chairman, Chief Exec. Officer and Pres
3.38M1.17M
Mr. Derica W. Rice , 51
Chief Financial Officer, Exec. VP of Global Services, Member of Operations Committee and Member of Policy & Strategy Committee
1.86M196.00K
Dr. Jan M. Lundberg Ph.D., 62
Exec. VP of Science & Technology and Pres of Lilly Research Laboratories
1.84M0.00
Mr. Michael J. Harrington , 53
Gen. Counsel and Sr. VP
1.30M14.00K
Mr. Enrique A. Conterno , 49
Sr. VP and Pres of Lilly Diabetes
1.16M117.00K
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders